ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
09-2000 | 06-2000 | 03-2000 | 12-1999 | |
Sales | 60 | 62 | 60 | 0 |
Gross Profit | 60 | 62 | 60 | N/A |
Operating Expenses | 681 | 1,496 | 516 | 0 |
Operating Income | -621 | -1,434 | -456 | N/A |
Pre-tax Income | -621 | -1,434 | -456 | 0 |
Net Income Continuous | -621 | -1,434 | -456 | N/A |
Net Income | $-621 | $-1,434 | $-456 | $N/A |
EPS Basic Total Ops | -3.60 | -7.20 | -3.60 | N/A |
EPS Basic Continuous Ops | -3.88 | -8.98 | -2.86 | N/A |
EPS Diluted Total Ops | -3.60 | -7.20 | -3.60 | N/A |
EPS Diluted Continuous Ops | -3.88 | -8.98 | -2.86 | N/A |
EBITDA(a) | $-596 | $-1,410 | $-432 | $N/A |